JEG-3 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The JEG-3 cell line is derived from a human choriocarcinoma, a type of cancer that originates from trophoblastic cells in the placenta. These cells exhibit properties characteristic of trophoblasts, including the ability to produce hormones such as human chorionic gonadotropin (hCG), which is crucial for pregnancy maintenance. JEG-3 cells are epithelial in nature and are often utilized in research focused on placental function, cancer biology, and endocrine signaling. JEG-3 cells are known for their aggressive growth characteristics and capacity to invade surrounding tissues, making them a valuable model for studying the mechanisms of trophoblastic tumor invasion and metastasis. Additionally, they have been used extensively in research investigating the molecular pathways involved in placental development, as well as the role of trophoblasts in immune tolerance during pregnancy. The cells are typically cultured in RPMI-1640 medium supplemented with fetal bovine serum and other growth factors to support their proliferation and maintenance. This cell line provides a robust platform for investigating placental cancer biology, hormone production, and the interaction between trophoblasts and the maternal immune system. |
|---|---|
| Organism | Human |
| Tissue | Placenta |
| Disease | Choriocarcinoma |
| Metastatic site | Brain |
| Applications | Transfection host |
| Synonyms | Jeg-3, JEG3, Jeg3, jeg3 |
Characteristics
| Age | Fetus |
|---|---|
| Gender | Male |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | JEG-3 (Cytion catalog number 300222) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0363 |
Biomolecular Data
| Isoenzymes | PGM3, 1-2, PGM1, 1, ES-D, 1, AK-1, 1, GLO-1, 1-2, G6PD, type B |
|---|---|
| Tumorigenic | Forms malignant tumor consistent with choriocarcinoma |
| Products | HCG, human chorionic somatomammotrophin (placental lactogen), progesterone. |
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS and 1% NEAA |
| Dissociation Reagent | Accutase |
| Doubling time | 36 hours |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 2 x 104 cells/cm2 will result in a confluent monolayer within 2 to 3 days. |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | Allow the cells to recover from the freezing process for 24 to 48 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300222-130625 | Certificate of Analysis | 18. Aug. 2025 | 300222 |
| 300222-612 | Certificate of Analysis | 23. May. 2025 | 300222 |